Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why

As of the April 24 closing, the banal carries a powerfully bullish statement sentiment. With a terms people of $86.71, it yields much than 126% upside potential. It received Buy ratings from each 8 analysts who provided coverage.

Pressmaster/Shutterstock.com

On March 26, Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) filed a Marketing Authorization Application with the National Health Surveillance Agency successful Brazil for Palsonify, a caller once-daily orally administered somatostatin receptor subtype 2 selective non-peptide agonist, for the attraction of acromegaly successful big patients.

Founder and CEO of Crinetics, Scott Struthers, has observed that this exertion marks yet different landmark connected a planetary level. The once-a-day oral Palsonify medicine has revolutionized the attraction protocol aft its support by the FDA successful the United States. The submission is based connected information collected from eighteen objective trials, 2 of which were Phase 3 trials with affirmative results for some superior and secondary endpoints.

The cause was highly tolerable, producing biochemical and symptomatic control, compared to placebo. In Europe, the CHMP precocious issued a affirmative sentiment successful narration to the MAA exertion of Crinetics.

Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is engaged successful processing and selling of innovative treatments for uncommon endocrine diseases and endocrine-related tumors. The institution offers a scope of therapies that are presently successful antithetic stages of objective trials. These see Paltusotine, Atumelnant, CRN09682, oral GLP-1 and GIP nonpeptide.

While we admit the imaginable of CRNX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.